Literature DB >> 12098846

Stability-indicating spectrophotometric and densitometric methods for determination of aceclofenac.

Y S el-Saharty1, M Refaat, S Z el-Khateeb.   

Abstract

Three methods were developed for the determination of aceclofenac in the presence of its degradation product, diclofenac. In the first method, third-derivative spectrophotometry (D3) is used. The D3 absorbance is measured at 283 nm where its hydrolytic degradation product diclofenac does not interfere. The suggested method shows a linear relationship in the range of 4-24 micrograms mL-1 with mean percentage accuracy of 100.05 +/- 0.88. This method determines the intact drug in the presence of up to 70% degradation product with mean percentage recovery of 100.42 +/- 0.94. The second method depends on ratio-spectra first-derivative (RSD1) spectrophotometry at 252 nm for aceclofenac and at 248 nm for determination of degradation product over concentration ranges of 4-32 micrograms mL-1 for both aceclofenac and diclofenac with mean percentage accuracy of 99.81 +/- 0.84 and 100.19 +/- 0.72 for pure drugs and 100.17 +/- 0.94 and 99.73 +/- 0.74 for laboratory-prepared mixtures, respectively. The third method depends on the quantitative evaluation of thin-layer chromatography of aceclofenac using chloroform:methanol: ammonia (48:11.5:0.5 v/v/v) as a mobile phase. Chromatograms were scanned at 274 and 283 nm for aceclofenac and diclofenac, respectively. The method determined aceclofenac and diclofenac in concentration ranges of 2-10 and 1-9 micrograms spot-1 with mean percentage accuracy of 100.20 +/- 1.03 and 100.14 +/- 0.98 for pure drugs and 99.77 +/- 0.74 and 100.07 +/- 0.78 for laboratory-prepared mixtures, respectively. This method retains its accuracy in the presence of up to 80% degradation product for the studied drug. The suggested procedures were checked using laboratory-prepared mixtures and were successfully applied for the analysis of their pharmaceutical preparation. The validity of the proposed methods was further assessed by applying a standard addition technique. The obtained results agreed statistically with those obtained by the reported method.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098846     DOI: 10.1081/ddc-120003453

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  6 in total

1.  Development and validation of simultaneous spectrophotometric methods for drotaverine hydrochloride and aceclofenac from tablet dosage form.

Authors:  S A Shah; D R Shah; R S Chauhan; J R Jain
Journal:  Indian J Pharm Sci       Date:  2011-05       Impact factor: 0.975

2.  Application of HPLC for the simultaneous determination of aceclofenac, paracetamol and tramadol hydrochloride in pharmaceutical dosage form.

Authors:  Preeti Chandra; Atul Singh Rathore; Sathiyanarayanan Lohidasan; Kakasaheb Ramoo Mahadik
Journal:  Sci Pharm       Date:  2012-01-31

3.  RP-LC gradient elution method for simultaneous determination of thiocolchicoside, aceclofenac and related impurities in tablet formulation.

Authors:  Pradnya A Karbhari; Sneha J Joshi; Suvarna I Bhoir
Journal:  J Pharm Bioallied Sci       Date:  2014-10

4.  Study of efficiency and spectral resolution for mathematical filtration technique using novel unlimited derivative ratio and classical univariate spectrophotometric methods for the multicomponent determination-stability analysis.

Authors:  Hayam Mahmoud Lotfy; Dina Abbas Ahmed; Mohamed Khaled Abdel Rahman; Soheir Abdel Fattah Weshahy
Journal:  Heliyon       Date:  2019-05-09

5.  Simple spectrophotometric methods for estimation of aceclofenac from bulk and formulations.

Authors:  A Bose; Pp Dash; Mk Sahoo
Journal:  Pharm Methods       Date:  2010-10

6.  Development and validation of UV-Visible spectrophotometric baseline manipulation methodology for simultaneous analysis of drotraverine and etoricoxib in pharmaceutical dosage forms.

Authors:  Vishnu P Choudhari; Sanket R Parekar; Subhash G Chate; Pradeep D Bharande; Bhanudas S Kuchekar
Journal:  Pharm Methods       Date:  2011-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.